نتایج جستجو برای: parp inhibitors

تعداد نتایج: 192891  

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1999
A A Pieper D J Brat D K Krug C C Watkins A Gupta S Blackshaw A Verma Z Q Wang S H Snyder

Streptozotocin (STZ) selectively destroys insulin-producing beta islet cells of the pancreas providing a model of type I diabetes. Poly(ADP-ribose) polymerase (PARP) is a nuclear enzyme whose overactivation by DNA strand breaks depletes its substrate NAD+ and then ATP, leading to cellular death from energy depletion. We demonstrate DNA damage and a major activation of PARP in pancreatic islets ...

Journal: :Carcinogenesis 2013
Hideaki Ogiwara Ayako Ui Bunsyo Shiotani Lee Zou Akira Yasui Takashi Kohno

Inhibitors of poly(ADP-ribose) polymerase (PARP) are promising anticancer drugs, particularly for the treatment of tumors deficient in the DNA damage response (DDR). However, it is challenging to design effective therapeutic strategies for use of these compounds against cancers without DDR deficiencies. In this context, combination therapies in which PARP inhibitors are used alongside DDR inhib...

Journal: :Cancer research 2011
Victoria E Anderson Michael I Walton Paul D Eve Katherine J Boxall Laurent Antoni John J Caldwell Wynne Aherne Laurence H Pearl Antony W Oliver Ian Collins Michelle D Garrett

CHK2 is a checkpoint kinase involved in the ATM-mediated response to double-strand DNA breaks. Its potential as a drug target is still unclear, but inhibitors of CHK2 may increase the efficacy of genotoxic cancer therapies in a p53 mutant background by eliminating one of the checkpoints or DNA repair pathways contributing to cellular resistance. We report here the identification and characteriz...

2013
Khanh Do Alice P. Chen

Poly (ADP-ribose) polymerases (PARP) are a family of nuclear protein enzymes involved in the DNA damage response. The role of PARP-1 in base excisional repair has been extensively characterized. More recent in vitro studies additionally implicate a role for PARP-1 in facilitating homologous recombination and nonhomologous end-joining. The more faithful process of homologous recombination repair...

Journal: :International journal of molecular medicine 2007
Jon G Mabley Rebecca Wallace Pál Pacher Kanneganti Murphy Csaba Szabó

Vitamin D is well characterized for its role in mineral homeostasis and maintenance of normal skeletal architecture. Vitamin D has been demonstrated to exert anti-inflammatory effects in a variety of disease states including diabetes, arthritis and inflammatory bowel disease. In these diseases poly[adenosine diphosphate (ADP)-ribose] polymerase (PARP) inhibitors have also proved effective as an...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2013
Khanh Do Alice P Chen

Poly (ADP-ribose) polymerases (PARP) are a family of nuclear protein enzymes involved in the DNA damage response. The role of PARP-1 in base excisional repair has been extensively characterized. More recent in vitro studies additionally implicate a role for PARP-1 in facilitating homologous recombination and nonhomologous end-joining. The more faithful process of homologous recombination repair...

2014
Csaba Hegedűs László Virág

Oxidative stress can cause DNA breaks which induce activation of the DNA nick sensor enzyme poly(ADP-ribose) polymerase-1 (PARP-1), part of the 17 member PARP enzyme family. PARP-1 modifies target proteins by attaching to them several NAD-derived ADP-ribose units forming poly(ADP-ribose) (PAR) polymers. PARylation controls many cellular processes while intense PARylation may also lead to cell d...

Journal: :PloS one 2016
Robert J Cardnell Ying Feng Seema Mukherjee Lixia Diao Pan Tong C Allison Stewart Fatemeh Masrorpour YouHong Fan Monique Nilsson Yuqiao Shen John V Heymach Jing Wang Lauren A Byers

Small cell lung cancer (SCLC) is an aggressive malignancy with limited treatment options. We previously found that PARP is overexpressed in SCLC and that targeting PARP reduces cell line and tumor growth in preclinical models. However, SCLC cell lines with PI3K/mTOR pathway activation were relatively less sensitive to PARP inhibition. In this study, we investigated the proteomic changes in PI3K...

Journal: :OncoReview 2023

Purpose of the review: This comprehensive review aims to provide a summary current research on utilization olaparib, poly(ADP-ribose) polymerase (PARP) inhibitor, in treatment ovarian cancer. The highlight key findings from recent clinical trials and assess potential olaparib as targeted therapy for improving prognosis cancer patients.
 Recent findings: Ovarian remains significant global h...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید